2-hydrazino-6-isopropylpyrimidin-4(3H)-one, 95.0%, 500mg

(3R,5R)-1-(tert-Butylsulfonyl)-5-(2,5-difluorophenyl)pyrrolidin-3-ol, 98%, 5g

6-BROMO-2,8-DIMETHYLIMIDAZO[1,2-A]PYRAZINE, 95%, 250mg

(S)-1-(NAPHTHALEN-2-YL)ETHANAMINE HCL, 95.0%, 250mg

(4aR,5R,6S)-4a-Hydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-vinyl-4,4a,5,6-tetrahydropyrano[3,4-c]pyran-1(3H)-one, 97%, 100mg

4'-Fluoro-3'-trifluoromethyl-biphenyl-3-carboxylic acid, 95.0%, 1g

3-(4-Methoxyphenoxy)pyrrolidine hydrochloride, 97%, 1g

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dimethylphenyl)propanoic acid, 98%, 250mg

sodium 2-(1,3-benzothiazol-2-yl)acetate, 1g

5-Cyano-2-thiophenecarboxaldehyde, 95.0%, 5g

Methylamine, 40% in water, for synthesis, 1 L, plastic bottle.

3-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline, 97.0%, 250mg

3,4,5-Trimethylphenol, 98%, 1g